Loading...

Stratec SE

SBS.DEXETRA
Healthcare
Medical - Devices
17.70
-0.08(-0.45%)
German Market opens in 51h 56m

Stratec SE Fundamental Analysis

Stratec SE (SBS.DE) shows weak financial fundamentals with a PE ratio of -889.09, profit margin of -0.10%, and ROE of -0.10%. The company generates $0.3B in annual revenue with weak year-over-year growth of -4.73%.

Key Strengths

Cash Position10.72%
Current Ratio3.97

Areas of Concern

ROE-0.10%
Operating Margin3.95%
PEG Ratio8.76
We analyze SBS.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 18.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
18.1/100

We analyze SBS.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

SBS.DE struggles to generate sufficient returns from assets.

ROA > 10%
-0.05%

Valuation Score

Moderate

SBS.DE shows balanced valuation metrics.

PE < 25
-889.09
PEG Ratio < 2
8.76

Growth Score

Weak

SBS.DE faces weak or negative growth trends.

Revenue Growth > 5%
-4.73%
EPS Growth > 10%
4.76%

Financial Health Score

Excellent

SBS.DE maintains a strong and stable balance sheet.

Debt/Equity < 1
0.56
Current Ratio > 1
3.97

Profitability Score

Weak

SBS.DE struggles to sustain strong margins.

ROE > 15%
-10.18%
Net Margin ≥ 15%
-0.10%
Positive Free Cash Flow
No

Key Financial Metrics

Is SBS.DE Expensive or Cheap?

P/E Ratio

SBS.DE trades at -889.09 times earnings. This suggests potential undervaluation.

-889.09

PEG Ratio

When adjusting for growth, SBS.DE's PEG of 8.76 indicates potential overvaluation.

8.76

Price to Book

The market values Stratec SE at 0.91 times its book value. This may indicate undervaluation.

0.91

EV/EBITDA

Enterprise value stands at 3.15 times EBITDA. This is generally considered low.

3.15

How Well Does SBS.DE Make Money?

Net Profit Margin

For every $100 in sales, Stratec SE keeps $-0.10 as profit after all expenses.

-0.10%

Operating Margin

Core operations generate 3.95 in profit for every $100 in revenue, before interest and taxes.

3.95%

ROE

Management delivers $-0.10 in profit for every $100 of shareholder equity.

-0.10%

ROA

Stratec SE generates $-0.05 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.05%

Following the Money - Real Cash Generation

Operating Cash Flow

Stratec SE generates limited operating cash flow of $-433.00K, signaling weaker underlying cash strength.

$-433.00K

Free Cash Flow

Stratec SE generates weak or negative free cash flow of $-11.50M, restricting financial flexibility.

$-11.50M

FCF Per Share

Each share generates $-0.95 in free cash annually.

$-0.95

FCF Yield

SBS.DE converts -5.34% of its market value into free cash.

-5.34%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-889.09

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

8.76

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.91

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.86

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.56

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.97

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How SBS.DE Stacks Against Its Sector Peers

MetricSBS.DE ValueSector AveragePerformance
P/E Ratio-889.0929.94 Better (Cheaper)
ROE-0.10%738.00% Weak
Net Margin-0.10%-575975.00% (disorted) Weak
Debt/Equity0.560.44 Weak (High Leverage)
Current Ratio3.974.49 Strong Liquidity
ROA-0.05%-15756.00% (disorted) Weak

SBS.DE outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Stratec SE's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

14.67%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

9.45%

Industry Style: Defensive, Growth, Innovation

Growing

FCF CAGR

126.01%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ